SERPINC1 and COVID-19: Understanding the role of ATIII in SCV2 infection could lead to new therapeutic strategies that enhance ATIII activity or prevent its displacement from endothelial cells, thereby reducing thrombotic and inflammatory complications in COVID-19 patients.